125碘标记的因子VIII在血管性血友病患者中的存活情况。 - Suppr | 超能文献

Survival of iodine-125-labeled factor VIII in patients with von Willebrand's disease.

作者信息

Over J, Sixma J J, Bouma B N, Bolhuis P A, Vlooswijk R A, Beeser-Visser N H

出版信息

J Lab Clin Med. 1981 Mar;97(3):332-44.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Survival of iodine-125-labeled factor VIII in patients with von Willebrand's disease.125碘标记的因子VIII在血管性血友病患者中的存活情况。

J Lab Clin Med. 1981 Mar;97(3):332-44.

2

Factor VIII-related activities in normal, haemophilic and von Willebrand's disease platelet fractions.正常、血友病及血管性血友病患者血小板组分中与凝血因子VIII相关的活性

Thromb Haemost. 1978 Oct 31;40(2):288-301.

3

Studies on the pathophysiology and treatment of von Willebrand's disease. III. Binding of plasma factor VIII to platelets in the presence of ristocetin.血管性血友病的病理生理学与治疗研究。III. 瑞斯托霉素存在下血浆因子VIII与血小板的结合

Nihon Ketsueki Gakkai Zasshi. 1981 Jul;44(4):910-20.

4

Von Willebrand's disease.血管性血友病

Prog Hemost Thromb. 1976;3:231-87.

5

[Pathophysiology of platelet anomalies and its analysis. (4). Abnormality of the platelet function in von Willebrand's disease].血小板异常的病理生理学及其分析。（4）血管性血友病中血小板功能异常

Rinsho Byori. 1983 Nov;31(11):1176-85.

6

Von Willebrand's disease. Clinical picture, diagnosis, and treatment.血管性血友病。临床表现、诊断及治疗。

Clin Lab Med. 1984 Jun;4(2):303-17.

7

Properties of post-infusion factor VIII in von Willebrand's disease.

Thromb Res. 1974 Aug;5(2):111-23. doi: 10.1016/0049-3848(74)90062-0.

8

Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.125碘标记的凝血因子VIII在正常人和典型血友病患者体内的存活情况。关于人凝血因子VIII异质性的观察。

J Clin Invest. 1978 Aug;62(2):223-34. doi: 10.1172/JCI109120.

9

Von Willebrand's syndrome. Studies on a variant factor VIII.血管性血友病。关于一种变异的凝血因子VIII的研究。

Haemostasis. 1976;5(5):276-84. doi: 10.1159/000214146.

10

Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.对3型血管性血友病患者体内产生的两种同种抗体的图谱绘制及功能研究。

Thromb Haemost. 2000 Feb;83(2):274-81.

引用本文的文献

1

Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A.针对内皮细胞表达 FVIII 可产生可释放的 FVIII 池，并可恢复血友病 A 小鼠模型的止血功能。

Blood. 2010 Oct 21;116(16):3049-57. doi: 10.1182/blood-2010-03-272419. Epub 2010 Jul 6.

2

The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII.人凝血因子VIII与血管性血友病因子之间的相互作用。因子VIII上高亲和力结合位点的特性。

Biochem J. 1989 Feb 1;257(3):679-83. doi: 10.1042/bj2570679.

3

Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome.血管性血友病因子抗原升高是非肺源性脓毒症综合征中急性肺损伤的早期血浆预测指标。

J Clin Invest. 1990 Aug;86(2):474-80. doi: 10.1172/JCI114733.

4

The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.

Biochem J. 1991 Feb 15;274 ( Pt 1)(Pt 1):257-61. doi: 10.1042/bj2740257.